Abe, M., Okada, K., Suzuki, H., Yoshida, Y., & Soma, M. (2013). T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease. BioMed Central.
Citação norma ChicagoAbe, Masanori, Kazuyoshi Okada, Hiroko Suzuki, Yoshinori Yoshida, and Masayoshi Soma. T/L-type Calcium Channel Blocker Reduces the Composite Ranking of Relative Risk According to New KDIGO Guidelines in Patients With Chronic Kidney Disease. BioMed Central, 2013.
Citação norma MLAAbe, Masanori, et al. T/L-type Calcium Channel Blocker Reduces the Composite Ranking of Relative Risk According to New KDIGO Guidelines in Patients With Chronic Kidney Disease. BioMed Central, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.